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ABSTRACT
Background: Invasive infections with non-beta-haemolytic streptococci (NBHS) is quite common and presents the clinicians
with difficulties regarding which patients are at risk for infective endocarditis (IE). The HANDOC score was developed to
identify patients with NBHS bacteraemia who are at low risk of IE. This study was conducted to validate HANDOC in an
external cohort.
Methods: Patients with NBHS in blood cultures between March and September 2016 in a Danish centre were included as
part of an on-going study. Patient characteristics were collected to classify bacteria according to Dukes criteria and the
components of the HANDOC score were collected retrospectively from the patients’ medical records.
Results: 68 patients were included in the cohort, of which 16 fulfilled Dukes criteria for IE. All patients with IE (16 of 16)
had a HANDOC score above the predefined cut-off. Cases of IE were found in patients with. Streptococcus mitis,
Streptococcus bovis, Streptococcus mutans, Streptococcus anginosus, and Streptococcus sanguinis group streptococci. The
HANDOC score thus had a sensitivity of 100% and a specificity of 62% in this cohort.
Conclusions: HANDOC has a sensitivity of 100% and a relatively high specificity (62%) also in a prospectively enrolled
cohort of patients from another country than its origin. This indicates that HANDOC can be implemented in clinical prac-
tice to identify patients with a low risk of IE in whom echocardiography can be omitted.
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Introduction
Bloodstream infection with non-beta-haemolytic strepto-
cocci (NBHS) is not unusual [1]. Infective endocarditis (IE)
is a serious infection and NBHS are among the most
commonly isolated pathogens [2–5]. IE is, however, only
diagnosed in a small proportion of patients with NBHS
bacteraemia [6]. The diagnosis of IE is mainly based on
microbiological findings in blood combined with find-
ings on transesophageal echocardiography (TEE) [7,8].
Since TEE is not available at all hospitals, not available
at all hours of the day and is uncomfortable for the
patient, it seems reasonable to perform this investiga-
tion on patients with NBHS bacteraemia at substantial
risk for IE. To guide clinicians when to pursue IE investi-
gations in NBHS bacteraemia, the HANDOC score was
developed and published in 2017 [6]. HANDOC is a
score system developed to estimate the risk of IE in
patients with bacteraemia caused by NBHS. With a cut-
off between 2 and 3 points, one point is given for the
presence of heart murmur or heart valve disease (H).
One point is added if the aetiological organism is in the
S. bovis, S. mutans or S. sanguinis groups, and subtracted
if it is in the S. anginosus group (A). One point is also
added if the number of positive cultures is two or more
(N), one if the duration of symptoms is one week or
more (D), one if there is only one species in the blood
cultures (O), and one point if the infection is commu-
nity-acquired (C) [6]. In the original study, the score was
validated using a separate control cohort from the same
geographical area. The present study was conceived to
evaluate the HANDOC score using a prospectively
enrolled cohort of patients with NBHS at a different geo-
graphical location.
Methods
Patients were included prospectively as part of an
ongoing study on the use of echocardiography in bac-
teraemia with Gram-positive bacteria. Inclusion was
based upon having a positive blood culture that was
analyzed at North Zealand Hospital and Herlev-Gentofte
Hospital (both located in Denmark) between March and
September 2016. According to local guidelines, trans-
thoracic echocardiography (TTE) and TEE was recom-
mended whenever a blood culture with growth of a
Gram-positive bacterium typically found in IE
(Staphylococcus aureus, NBHS, Enterococcus faecalis or
coagulase-negative staphylococci (in 2 bottles)) was
encountered. Data from the medical records was used
to gain information about variables in the modified
Duke criteria [7,8] and HANDOC scores [6,7] (permit
from Data Protection Agency 2012-58-0004 (3-3013-
1845/1)). Bacterial isolates were classified according to
the original HANDOC study [6] (Table 1).
The patients were classified in the same way as in the
original HANDOC study, and were considered to have IE
if they fulfilled the modified Duke criteria for definite IE.
If they did not fulfil the modified Duke criteria, they
were classified as IE excluded or unknown. IE was
excluded if either (1) a TEE was performed with no signs
of IE or (2) the patient received an antibiotic treatment
of less than 3weeks in total with less than 14 days being
intravenous and survived at least 6months after inclu-
sion in the study and without a relapse of bacteraemia.
Statistical analysis was performed using SPSS 25 (IBM,
Armonk, NY) and MedCalc (MedCalc software bvba). Chi-
square and Student’s t test for comparisons of propor-
tions and means, respectively.
Results
The clinical and microbiological characteristics of the 68
included patients are shown in Table 2. IE was con-
firmed in 16 patients and in 52 patients IE was not pre-
sent. Of 52 patients without IE, IE was excluded in 46
patients. Patients with IE were older (81 versus 76 years
old) though the difference was not statistically signifi-
cant. The gender distribution was similar in all groups
with men constituting around 60% of patients.
Table 1. Components of the HANDOC-score [6].
Variable Components of score Points given or subtracted
Heart murmur or valvular disease 1
Aetiology S. bovis group 1
S. mutans group 1
S. sanguinis group 1
S. anginosus group 1
S. mitis group 0
S. salivarius group 0
Number of positive blood cultures  2 1
Duration of symptoms  7 days 1
Only one species in blood cultures 1
Community acquired infection 1
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TEE was performed on 55% of the patients. All but
one of the patients with confirmed IE (94%) underwent
TEE as compared to 50% of the patients where IE was
excluded. All patients with IE underwent either TTE or
TEE, compared to 64% of the patients without IE.
Echocardiography was performed on 18 of the 33
patients with a HANDOC score below the cut off level of
3 points. The number needed to screen was 2.3 (95% CI
1.6–3.7) employing HANDOC. In the population studied
the positive predictive value was 46% (95% CI 37–54)
and the negative predictive value was 100%.
When the HANDOC score was used to distinguish
patients with IE from other patients the sensitivity was
100% (95% CI 79.4–100) and the specificity was 62%
(95% CI 47–75) (Figure 1). If patients from the unknown
group were excluded from the analysis, the resulting
sensitivity of HANDOC was still 100% whereas the speci-
ficity was 59% (95% CI 46–72).
Discussion
In this study on NBHS bacteraemia, the proportion of
patients with IE was higher than in the recently pub-
lished HANDOC study (24% compared to 8.5%). The rate
of TEE was higher than in the original study (55% versus
12%, p< .001). HANDOC has excellent sensitivity to
detect patients with IE in the present cohort but the
specificity (58%) is lower than the one found in the ori-
ginal study (73%). This might be explained by a signifi-
cantly higher proportion of cases having only one
bacterial species reported in blood culture in this study
than in the original study (80% versus 63%, p¼ .007),
which in turn might be due to different microbiological
demographics, to differences in when and how to take
blood cultures, or to differences in how the microbio-
logical laboratories identify and report findings. IE
caused by S. anginosus group Streptococcus was not as
uncommon in this cohort as in the original study (19%
versus 0%, p< .001), possibly due to different patient
background or to different criteria for when to perform
echocardiography. The patients with IE caused by S.
anginosus were identified by the HANDOC score, how-
ever, and the design of this validation study is not
appropriate for suggesting changes to the HANDOC
score. The distribution of bacteria in the different
streptococcal groups was similar to the distribution in
the original study, though the proportion of S. bovis
group isolates was somewhat larger. The clinical charac-
teristics of the patients were also similar to those in the
original study.
An obvious limitation of the present study is that the
cohort is relatively small. We can thus not exclude that
Table 2. Clinical and microbiological characteristics in relation to IE.
All cases
n¼ 68
IE confirmed
n¼ 16
IE unknown
n¼ 6
IE excluded
n¼ 46
p value, IE confirmed
versus excluded
Age, median (range) 72 (27–95) 81 (42–89) 69.5 (52–89) 75.5 (27–68) .23
Gender, male 41 (60) 10 (63) 3 (50) 28 (61) .91
Heart valve disease or heart murmur, no 21 (31) 9 (56) 0 (0) 12 (26) .029
Heart valve disease, no 16 (24) 6 (38) 0 (0) 10 (22) .22
Heart murmur, no 12 (18) 7 (44) 5 (11) .0045
S. mitis group 16 (24) 2 (13) 1 (17) 13 (28) .2
S. salivarius group 7 (10) 0 (0) 0 (0) 7 (15) .1
S. bovis group 15 (22) 6 (38) 1 (17) 8 (17) .1
S. mutans group 4 (5.9) 2 (13) 0 (0) 2 (4.3) .25
S. sanguinis group 8 (12) 3 (19) 0 (0) 5 (11) .42
S. anginosus group 18 (26) 3 (19) 4 (67) 11 (24) .68
At least two positive blood cultures 44 (65) 16 (100) 4 (67) 24 (52) <.001
Symptom duration of >1 week 17 (25) 8 (50) 2 (33) 7 (15) .0055
Only one bacterial species 55 (80) 14 (88) 4 (67) 37 (80) .53
Community acquired, no 33 (49) 10 (63) 1 (17) 22 (48) .31
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Figure 1. Receiver operating characteristic curve for the ability of
HANDOC to separate patients with and without IE in this cohort.
The inset shows the number of episodes of IE and non-IE in relation
to the HANDOC score.
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HANDOC can miss cases of IE. A strength of the study is
that the proportion of patients undergoing TEE was
higher than in many previous studies on risk for IE in
bacteraemia [6,9–11]. This makes it less likely that cases
of IE were missed. In conclusion, the results show that
HANDOC can be used to safely identify patients with
NBHS where the risk of IE is so low that further IE inves-
tigations might be unnecessary. If other factors, not
accounted for in the HANDOC score, lead the physician
to suspect IE a low HANDOC score should of course not
exclude the patient from TEE.
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